| Financial Year |
March 31 2023 |
| Monetary Funds |
83,382,504.53 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
14,317,627.62 |
| Accounts Receivable |
1,820,679,280.09 |
| Advances to Suppliers |
226,864,812.46 |
| Other Receivables |
541,795,911.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
11,996,180.18 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
58,200,990.48 |
| Total Current Assets |
6,327,815,211.22 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
363,915,947.26 |
| Fixed Assetes |
981,937,049.41 |
| Under-construction Projects |
970,873.80 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
207,829,700.28 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,485,655.72 |
| Deferred Income Tax Assets |
313,412,704.91 |
| Other Non-Current Assets |
10,576,113.00 |
| Sub-Total of Non-Current Assets |
1,986,552,184.71 |
| Total Assets |
8,314,367,395.93 |
| Short-Term Loans |
1,679,376,387.78 |
| Trading Financial liabilities |
-- |
| Notes Payable |
34,471,524.40 |
| Accounts Payable |
1,428,205,063.63 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
56,635,316.70 |
| Taxes Payable |
177,751,593.50 |
| Interest Payable |
-- |
| Dividend Payable |
15,994,860.41 |
| Other payables |
1,378,014,125.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
54,605,830.80 |
| Other Current Liabilities |
369,267,921.60 |
| Sub-Total of Current Liabilities |
5,343,633,009.50 |
| Long-term Loans |
9,698,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
9,698,000.00 |
| Total Liabilities |
5,353,331,009.50 |
| Paid-In Capital(Or Share Stock) |
1,756,514,205.00 |
| Capital Surplus |
1,690,856,196.91 |
| Surplus Reserve |
174,966,515.89 |
| LESS:Treasury Stock |
52,024,962.00 |
| Undistributed Profits |
-669,456,969.06 |
| Minority Stockholder's Interest |
59,317,735.72 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,901,718,650.71 |
| Owner's Equity（Stockholder's Equity） |
2,961,036,386.43 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,314,367,395.93 |
